Product Description
SARS-CoV-2 WT Pseudovirus | 95-200 | ProSci
Product Type: Pseudovirus
Category: New/Featured Products
Research Area: Infectious Disease, COVID-19
Tested Applications: Neut, Viral Infection
Protocol:
1. Require BSL-2 or higher working environment
2. 5 μL per application (96-well plate) with at least 0.3 X 106 RLU / well.
3. Avoid freezing and thawing cycle to ensure the titer of the pseudovirus.
4. This product is for Research Use only
5. Neutralization assay protocol is available
Physical State: Liquid
Buffer: DMEM/10% FBS
Storage: The pseudovirus is stable in a liquid state at -70˚ for 12 months. Avoid repeated freeze-thaw cycles.
Additional Names: Spike glycoprotein Receptor-binding domain, S glycoprotein, Spike protein, pseudovirus, pseudovirus reporter, reporter virus particle
Protein Accession: QHD43416
Protein GI Number: 1791269090
NCBI Gene ID: 43740568
Background: SARS-CoV-2 Pseudovirus uses HIV pseudotyped with SARS-CoV-2 spike protein and firefly luciferase reporter. This pseudovirus effectively infects human ACE2-overexpressing cells and can be used to screen for inhibitors of Spike-ACE2 interaction, determine neutralizing antibody titers, and is a valuable tool for COVID-19 vaccine development as well.